Cargando…

Characteristics of In2G Variant in Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency

Substantial research has been performed during the last decades on the clinical and genetic variability of congenital adrenal hyperplasia (CAH) and its most common form, 21-hydroxylase deficiency (21OHD). CAH is one of the most prevalent autosomal recessive diseases in humans, and it can be divided...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kocova, Mirjana, Concolino, Paola, Falhammar, Henrik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818746/ https://www.ncbi.nlm.nih.gov/pubmed/35140681 http://dx.doi.org/10.3389/fendo.2021.788812

Ejemplares similares

Clinical outcomes and characteristics of P30L mutations in congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Kocova, Mirjana, et al.
Publicado: (2020)

Quality of Life in Men With Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Verhees, Myrthe J. M., et al.
Publicado: (2021)

The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
por: Pignatelli, Duarte, et al.
Publicado: (2019)

Update on the Swedish Newborn Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Zetterström, Rolf H., et al.
Publicado: (2020)

Molecular diagnosis of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Espinosa Reyes, Tania Mayvel, et al.
Publicado: (2020)

Corrigendum: The Complexities in Genotyping of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
por: Pignatelli, Duarte, et al.
Publicado: (2020)

Genotype-Phenotype Correlation in Patients with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency in Cuba
por: Espinosa Reyes, Tania Mayvel, et al.
Publicado: (2021)

Prevalence of CAH-X Syndrome in Italian Patients with Congenital Adrenal Hyperplasia (CAH) Due to 21-Hydroxylase Deficiency
por: Paragliola, Rosa Maria, et al.
Publicado: (2022)

Long-Term Health Outcomes of Korean Adults With Classic Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Lim, Seung Gyun, et al.
Publicado: (2021)

Sexuality in Males With Congenital Adrenal Hyperplasia Resulting From 21-Hydroxylase Deficiency
por: Gehrmann, Katharina, et al.
Publicado: (2019)

Genetic and clinical characteristics including occurrence of testicular adrenal rest tumors in Slovak and Slovenian patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Saho, Robert, et al.
Publicado: (2023)

Adrenocortical tumor in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Dung, Vu Chi, et al.
Publicado: (2015)

Birth Size in Neonates with Congenital Adrenal Hyperplasia due to 21-hydroxylase Deficiency
por: Dörr, Helmuth G., et al.
Publicado: (2019)

Congenital adrenal hyperplasia is a very rare cause of adrenal incidentalomas in Sweden
por: Sahlander, Fredrik, et al.
Publicado: (2022)

Cardiovascular Health in Children and Adolescents With Congenital Adrenal Hyperplasia Due to 21-Hydroxilase Deficiency
por: Improda, Nicola, et al.
Publicado: (2019)

Treatment and Outcome of Congenital Adrenal Hyperplasia: 21-Hydroxylase Deficiency
por: Lee, Peter A., et al.
Publicado: (2010)

THU207 11-oxygenated Androgens Are Strongly Associated With Treatment Quality In Children With Congenital Adrenal Hyperplasia Due To 21-Hydroxylase Deficiency
por: Abawi, Ozair, et al.
Publicado: (2023)

SUN-LB11 What Is the Value of Clinical Suspicion in Neonatal Screening for Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency (CAH 21OHD)?
por: Fernández, María Sanz, et al.
Publicado: (2020)

Concurrence of Meningomyelocele and Salt-Wasting Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
por: Kırmızıbekmez, Heves, et al.
Publicado: (2015)

Ectopic Adrenal Tumor in a Patient With Untreated Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Alba, Eva L, et al.
Publicado: (2021)

Congenital adrenal hyperplasia due to P450 oxidoreductase deficiency
por: Zhang, Jin, et al.
Publicado: (2022)

Pitfalls in molecular diagnosis of 21-hydroxylase deficiency in congenital adrenal hyperplasia
por: Kolahdouz, Mahsa, et al.
Publicado: (2015)

Long-Term Gynecological Outcomes in Women with Congenital Adrenal Hyperplasia due to 21-Hydroxylase Deficiency
por: Johannsen, T. H., et al.
Publicado: (2010)

Cardiovascular risk factors in children and adolescents with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Subbarayan, Anbezhil, et al.
Publicado: (2014)

A Rare Combination: Congenital Adrenal Hyperplasia Due To 21 Hydroxylase Deficiency and Turner Syndrome
por: Peltek Kendirci, Havva Nur, et al.
Publicado: (2012)

Recent advances in biochemical and molecular analysis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Choi, Jin-Ho, et al.
Publicado: (2016)

Testicular adrenal rest tumors in boys with 21-hydroxylase deficiency, timely diagnosis and follow-up
por: Kocova, Mirjana, et al.
Publicado: (2018)

Long-term cardiometabolic morbidity in young adults with classic 21-hydroxylase deficiency congenital adrenal hyperplasia
por: Righi, Beatrice, et al.
Publicado: (2023)

Pharmacogenetics of glucocorticoid replacement could optimize the treatment of congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Moreira, Ricardo P. P., et al.
Publicado: (2011)

Mineralocorticoid replacement during infancy for salt wasting congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Gomes, Larissa G., et al.
Publicado: (2013)

Rare and severe complications of congenital adrenal hyperplasia due to 21-hydroxylase deficiency: a case report
por: Ferreira, Florbela, et al.
Publicado: (2013)

Comparison of different glucocorticoid regimens in the management of classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Ajish, T. P., et al.
Publicado: (2014)

Genotype-phenotype correlations in children and adolescents with nonclassical congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Dörr, Helmuth-Günther, et al.
Publicado: (2020)

Bone Mineral Density in Adults With Congenital Adrenal Hyperplasia: A Systematic Review and Meta-Analysis
por: Rangaswamaiah, Swetha, et al.
Publicado: (2020)

Growth-Related Characteristics of Patients <18 Years of Age with Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency (21OHD): Real World Evidence from the I-CAH Registry
por: Farrar, Mallory, et al.
Publicado: (2021)

Phenotype of patients with congenital adrenal hyperplasia due to 11β-hydroxylase deficiency
por: Dung, Vu Chi, et al.
Publicado: (2015)

Are Current Normal Values of 11DOC Useful for Diagnosis of Non Classical Congenital Adrenal Hyperplasia Due to 11β- Hydroxylase Deficiency?
por: Barash, Galia, et al.
Publicado: (2021)

Height outcome of patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency: Evidence from recent data
por: Kamoun, Mahdi, et al.
Publicado: (2013)

Metabolic profile and cardiovascular risk factors in adult patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency
por: Mnif, Mouna Feki, et al.
Publicado: (2012)

A Case of Bilateral Testicular Tumors Subsequently Diagnosed as Congenital Adrenal Hyperplasia Due to 21-Hydroxylase Deficiency
por: Sha, Yan-Kun, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_1d9rkfe3i6rdl27lvd3p8661kt